west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "免疫抑制剂" 18 results
  • 肾移植手术后应用他克莫司引发巨细胞病毒性视网膜炎一例

    Release date:2021-05-21 06:03 Export PDF Favorites Scan
  • 肾移植手术后免疫抑制剂治疗18年引发巨细胞病毒性视网膜炎1例

    Release date:2022-11-16 03:11 Export PDF Favorites Scan
  • A Case Report of Auxiliary Liver-Intestinal Combined Transplantation

    【摘要】目的探讨肝肠联合移植的术式、免疫抑制治疗方案与效果。方法对一中年男性短肠综合征患者施行辅助性肝肠联合移植,术后患者免疫抑制治疗采用甲波尼龙(MP)、环孢素A(CsA)、环磷酰胺(CTX)与抗淋巴细胞球蛋白(ALG)处理。结果术后观察期内移植物存活良好。结论本例采用的免疫抑制治疗方案是成功的,且手术方法操作较为简便、易行。

    Release date:2016-09-08 11:53 Export PDF Favorites Scan
  • 免疫抑制剂在顽固性葡萄膜炎治疗中的应用

    糖皮质激素是治疗葡萄膜炎的首选药物,但长期应用具有明显的毒副作用,并且单一药物治疗对慢性或顽固性葡萄膜炎的疗效欠佳。选择性T细胞抑制剂、抗代谢药物、烷化剂、基因重组干扰素alpha;、抗肿瘤坏死因子单克隆抗体、中药类免疫调节剂等免疫抑制剂为顽固性葡萄膜炎的治疗提供了更加丰富的选择。由于不同类型免疫抑制剂的作用机制不同,各自适应证、疗效和毒副作用也不尽相同。在临床实践中,应根据葡萄膜炎的类型选择敏感的免疫抑制剂药物,同时密切观察其疗效和毒副作用。

    Release date:2016-09-02 05:41 Export PDF Favorites Scan
  • EFFECTS OF IMMUNOSUPPRESSANTS ON CULTURED RAT MACROPHAGES AND SCHWANN’S CELLS

    Objective To explore the effects of several immunosuppressants on the cell numbers of cultured rat macrophages and Schwann’s cells. Methods The macrophages and Schwann’s cells were cultured from the newborn Wistar rats. Different concentrations of methylprednisolone(10-3, 10-4,10-6 and 10-8 mol/L), CsA(10-5, 10-6, 10-7 and 10-8 mol/L) and FK506(10-6, 10-7, 10-8 and 10-9 mol/L) were administrated to the cells, while control group was given no drugs. Twentyfour, 48 and 72 hours after administration, the cells from different concentrations were measured with MTT methods respectively. Theresults were compared and analyzed statistically. Results Only high concentration methylprednisolone (10-4 mol/L) and a certain range of concentrations of CsA (10-6,10-7 and 10-8 mol/L) and FK506 (10-7,10-8 and 10-9 mol/L) can provide protection to culturedrat macrophages. Under most concentrations, CsA and FK506 had no effects onthe cell number of cultured rat Schwann’s cell. Only with high concentration CsA (10-5 mol/L) and methylprednisolone (10-3 mol/L) could significantly decreased the cell number of Schwann’s cell. Long time (72 hours) and low dosage (10-8 mol/L) administration of methylprednisolone could significantlyprotect Schwann’s cell. Conclusion High concentration methylprednisolone and some certain concentration CsA and FK506 can protect cultured rat macrophages. But high concentration CsA and methylprednisolone prohibit the proliferation of Schwann’s cells. Only long time and low dosage methylprednisolonecan protect cultured rat Schwann’s cells.

    Release date:2016-09-01 09:24 Export PDF Favorites Scan
  • Clinical characteristics and treatment of six kidney recipients with human parvovirus B19 infection

    ObjectiveTo investigate the diagnosis, clinical features, treatment and outcome of pure red cell aplasia (PRCA) caused by human parvovirus B19 (HPV-B19) infection in kidney recipients. Method The clinical courses of six patients with PRCA caused by HPV-B19 infection after renal transplantation in West China Hospital between May 2018 and April 2019 were retrospectively investigated. Results The six patients showed obvious anemia symptoms, lacking rash, joint pain and other clinical symptoms of viral infection. The hemoglobin level of five patients got totally remission from a course of intravenous immunoglobulin (IVIG) treatment, and anemia symptoms like fatigue, weakness got notable improvement. One patient had no improvement after two courses of IVIG treatment, and his anemia was significantly improved after the third IVIG course combined with immunosuppressant conversion(from tacrolimus to cyclosporine), and one patient with recurrence accepted a repeated course of IVIG treatment and obtained remission of severe anemia again. The median time of reticulocyte firstly rose to above 0.084×1012/L from the day of IVIG treatment ended was 3.50 (1.25, 5.00) days, and the median time required for a 30 g/L increase in hemoglobin to the end of IVIG treatment was 16.00 (9.25, 31.25) days. No serious adverse reactions occurred and all patients had stable graft function. Conclusions The main clinical manifestations of PRCA caused by HPV-B19 infection after kidney transplantation are anemia symptoms, lacking other clinical symptoms of viral infection. HPV-B19 DNA detection combined with blood routine examination, reticulocyte count and bone marrow cytology (or none) can diagnose HPV-B19 infection. High dose of IVIG is effective and safe, and a repeated course is still effective when the infection recurs. For refractory PRCA that IVIG monotherapy fail, a combination with conversion from tacrolimus to cyclosporine can effectively improve the anemia without graft dysfunction.

    Release date:2019-08-15 01:18 Export PDF Favorites Scan
  • 脉络膜结核瘤严重类赫氏反应1例

    Release date:2022-06-16 09:26 Export PDF Favorites Scan
  • Clinical Analysis of 7 Cases with Chronic Hepatitis B Relapse and Exacerbations Caused by Corticosteroids and Immunosuppressant Reactivation

    目的:探讨激素及免疫抑制剂导致乙肝病毒再激活所致的肝损害的危害性及治疗效果,指导临床治疗。方法:总结本院近2年收治的7例慢性乙肝病毒感染者在使用激素及免疫抑制剂致肝炎再激活并加重患者的临床资料进行分析。结果:慢性乙肝病毒感染者因各种原因使用激素及免疫抑制剂所导致的慢性乙肝的复发加重,病情发展迅速,病死率高。结论:抗乙肝病毒治疗是预防肝病复发并恶化的关键,在激素或免疫抑制剂治疗前和治疗中都应使乙肝病毒降至尽可能低的水平。

    Release date:2016-09-08 09:54 Export PDF Favorites Scan
  • Progress of immune checkpoint inhibitors in neoadjuvant therapy for esophageal cancer

    Neoadjuvant chemoradiotherapy or chemotherapy combined with surgery for locally advanced esophageal cancer has become the standard treatment, and despite the survival benefit, most patients still experience postoperative recurrence and distant metastasis. Immune checkpoint inhibitors play an anti-tumor role by activating T cells, and immunotherapy has become one of the important strategies for first-line and second-line treatment of advanced esophageal cancer with the continuous evolution of immunotherapy models. Regarding neoadjuvant immunotherapy for esophageal cancer, a large number of studies are being carried out and explored, which are expected to inject new vitality into neoadjuvant therapy for esophageal cancer. This article reviews the current clinical studies on neoadjuvant immunotherapy for esophageal cancer.

    Release date:2024-04-28 03:40 Export PDF Favorites Scan
  • ALLOGENEIC HUMERAL SHAFT TRANSPLANTATION WITH VASCULAR ANASTOMOSIS: TWENTY YEARS FOLLOW-UP

    OBJECTIVE: To sum up the clinical results of allogeneic humeral transplantation with vascular anastomosis, and evaluate the clinical significance. METHODS: From September to November 1979, 1 case with humeral shaft defect of 10 cm in length and 2 cases with tibia shaft defect of 12 cm in length were repaired by allogeneic humeral transplantation with vascular anastomosis. Azathiopurine and prednisone were applied for 3 months postoperatively. All cases were followed up for 20 years. RESULTS: Case 1 recovered well with good bone union and reconstruction after operation, and could work normally. In case 2, five chronic rejections were occurred during 3 years after operation, and recovered after treatment, the allograft bone was fractured after 2 years of operation, and unioned by autogeneous iliac bone transplantation. In case 3, the distal part of allograft bone was fractured after 46 months, and unioned by autogeneous iliac bone transplantation. The middle part of allograft bone was non-unioned after 20 years follow-up in case 3, but the patient could still work normally. CONCLUSION: The clinical results of allogeneic long bone transplantation can be improved by rational tissue matching test, application of effective immunosuppressive drugs in a certain period according to the principles of modern transplantation immunology.

    Release date:2016-09-01 10:21 Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content